Item 7.01 Regulation FD Disclosure.

On January 11, 2021, members of management of Aethlon Medical, Inc. (the "Company") will begin using the investor presentation attached as Exhibit 99.1 to this report in various meetings and industry conferences with investors, securities analysts and others. The Corporate Presentation is available under the "Investors" section of the Company's website.

The information in this Item 7.01 of this Current Report on 8-K (including Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, whether made before or after today's date, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such filing.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits.



Exhibit No.   Description
   99.1         Corporate presentation, dated January 11, 2021






















































  2

© Edgar Online, source Glimpses